Clinical trial

Study of Mepolizumab Safety Syringe in Asthmatics

NCT03021304

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-02-01

PhasePHASE3

Study timeline

Study start (actual)2017-02-01Date precision: day

Registry last updated2019-07-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

MepolizumabDRUG · verified · RxNorm: mepolizumab

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 BirminghamAlabama, United States1 CincinnatiOhio, United States1 MoscowRussia1 Saint PetersburgRussia1 AmsterdamNetherlands1 StockholmSweden1 LundSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03021304 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.